Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
- Conditions
- Head and Neck Cancer
- Interventions
- Behavioral: NYU Electronic Patient Visit Assessment (ePVA)Behavioral: Usual Care
- Registration Number
- NCT06030011
- Brief Summary
The PI and the research team developed the New York University (NYU) Electronic Patient Visit Assessment (ePVA) for head and neck cancer (HNC) as a patient-reported outcome measure (PRO) for the early detection of uncontrolled symptoms. The ePVA is digital patient-reported symptom monitoring system, providing actionable information at point-of-care that enables clinicians to provide real-time interventions. The study aims to advance the science of cancer care delivery by testing the effectiveness of the ePVA as a digital patient-reported monitoring system for patients with HNC in real-world settings and identify implementation strategies that optimize the effectiveness of the ePVA in diverse rural and urban settings. The study hypothesis is that participants assigned to the ePVA arm will have better swallowing, taste and smell, and social function than participants assigned to usual care arm at 4 weeks after completing radiation therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 270
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description NYU Electronic Patient Visit Assessment (ePVA) plus Usual Care Usual Care - NYU Electronic Patient Visit Assessment (ePVA) plus Usual Care NYU Electronic Patient Visit Assessment (ePVA) - Usual Care Usual Care -
- Primary Outcome Measures
Name Time Method Head and neck cancer (HNC) symptoms as assessed by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ) 4 weeks after completing radiation therapy The EORTC QLQ-C30 and QLQ-H\&N35 will be used to measure head and neck cancer symptoms, such as social function, senses of taste and smell, and swallowing. The scores will be summed and then transformed to a single score ranging from 0=Best to 100=Worst.
- Secondary Outcome Measures
Name Time Method Pain as assessed by EORTC QLQ-H&N35 Quality of Life Questionnaire (QLQ) 4 weeks after completing radiation therapy The EORTC QLQ-H\&N35 will be used to assess pain. The score will be summed and then transformed to a single score ranging from 0=Best to 100=Worst.
Health-Related Quality of Life (HRQoL) as assessed by the EORTC QLQ-C30 Quality of Life Questionnaire (QLQ) 4 weeks after completing radiation therapy The EORTC QLQ-H\&N35 will be used to assess Health-Related Quality of Life (HRQoL). The score will be summed and then transformed to a single score ranging from 0=Best to 100=Worst.
Acute Care Services Use as assessed by number of acute care visits 4 weeks after completing radiation therapy Acute Care Services Use is the use of services delivered in acute care settings, such as feeding tube placements, emergency room visits, and hospitalizations.
Acute Care Services Use as assessed by number of days of using acute care 4 weeks after completing radiation therapy Acute Care Services Use is the use of services delivered in acute care settings, such as feeding tube placements, emergency room visits, and hospitalizations.
Trial Locations
- Locations (5)
NYU Meyers College of Nursing
๐บ๐ธNew York, New York, United States
Fox Chase Cancer Center
๐บ๐ธPhiladelphia, Pennsylvania, United States
NYU Langone Perlmutter Cancer Center
๐บ๐ธNew York, New York, United States
UTHealth Houston Cizik School of Nursing
๐บ๐ธHouston, Texas, United States
University of Kansas Cancer Center
๐บ๐ธKansas City, Kansas, United States